HomeCOPN • VIE
add
Cosmo Pharmaceuticals NV
Previous close
€59.50
Day range
€60.50 - €61.00
Year range
€44.80 - €81.50
Market cap
977.55M CHF
Avg Volume
4.00
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
In the news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 25.86M | -62.04% |
Operating expense | 13.78M | -19.74% |
Net income | -1.00M | -102.82% |
Net profit margin | -3.88 | -107.42% |
Earnings per share | — | — |
EBITDA | 2.43M | -94.28% |
Effective tax rate | -202.99% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 126.62M | -5.09% |
Total assets | 610.33M | -4.37% |
Total liabilities | 143.35M | 7.89% |
Total equity | 466.98M | — |
Shares outstanding | 15.94M | — |
Price to book | 2.06 | — |
Return on assets | -0.29% | — |
Return on capital | -0.38% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.00M | -102.82% |
Cash from operations | 450.00K | -99.00% |
Cash from investing | 20.99M | 152.39% |
Cash from financing | -17.10M | -537.16% |
Net change in cash | 3.23M | 50.74% |
Free cash flow | 1.66M | -93.85% |
About
Founded
1997
Website
Employees
332
